Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-20T05:30:11.092Z Has data issue: false hasContentIssue false
  • English
  • Français

Frequency of Percutaneous Injuries Requiring Postexposure Prophylaxis for Occupational Exposure to Human Immunodeficiency Virus

Published online by Cambridge University Press:  02 January 2015

Maria Gilson Sistrom ,
Betty Joe Coyner ,
Jack M. Gwaltney Jr  and
Barry M. Farr
Maria Gilson Sistrom
Affiliation:
University of Virginia Health Sciences Center, Charlottesville, Virginia
Betty Joe Coyner
Affiliation:
University of Virginia Health Sciences Center, Charlottesville, Virginia
Jack M. Gwaltney Jr
Affiliation:
University of Virginia Health Sciences Center, Charlottesville, Virginia
Barry M. Farr*
Affiliation:
University of Virginia Health Sciences Center, Charlottesville, Virginia
*
University of Virginia Health Sciences Center, Hospital Epidemiology, Box 473, Charlottesville, VA 22908
Get access Rights & Permissions [Opens in a new window]

Abstract

New recommendations regarding prophylaxis of healthcare workers exposed to human immunodeficiency virus (HIV) prompted us to examine the frequency and nature of percutaneous injuries at this hospital. Four previously defined risk factors for transmission of HIV were evaluated. Between 1993 and 1995, 1,070 percutaneous injuries were reported, including 11 in which the source patient had acquired immunodeficiency syndrome (AIDS). Five of these injuries involved at least one risk factor for transmission. No source patient was found to have AIDS as a result of testing following exposure. We conclude that high-risk injuries are infrequent and that postexposure prophylaxis will not increase costs greatly at this medical center.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 7 , July 1998 , pp. 504 - 506
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1996;8(2):21.Google Scholar
2.Centers for Disease Control. Case-control study of HIV sero-conversion in health care workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995;44:929–933.Google Scholar
3.Centers for Disease Control and Prevention. Update: provisional public health service recommendations for chemopro-phylaxis after occupational exposure to HIV. MMWR 1996;45:468–472.Google Scholar
4.Beekmann, SE, Fahrner, R, Gerberding, JL, Koziol, D, Henderson, DK. Risk factors for HIV seroconversion in a prospective study of zidovudine (ZDV) post-exposure prophylaxis (PEP). In: Program and Abstracts of the Infectious Diseases Society of America 34th Annual Meeting; 09 18-20, 1996; New Orleans, LA. Abstract 26.Google Scholar
5.Carpenter, C, Fischl, MA, Hammer, SM, Hirsch, MS, Jacobsen, DM, Katzenstein, DA, et al.Antiretroviral therapy for HIV infection in 1996. JAMA 1996;276:146–154.Google Scholar